Lallemand Pharma

Lallemand Pharma, a Switzerland based company, possesses the intellectual property rights of an immunostimulant drug indicated in the prevention of respiratory infections known as PMBL sublingual tablet brought rights of IMC off-the-shelf portal www_dot_allabouth1n1flu_dot_com.

IMC conceptualized, designed and developed a H1N1 awareness portal focusing on physician education for better patient care.


The portal featured KOL, regular updates on H1N1 medications, treatments, Swineflu guide for patient educations, expert review from doctors and news updates specific to H1N1.

Success Stories

Yes, IMC can help you in your digital journey.

Trusted supplier and partner since 2008
Permission to Communicate*